These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29391154)

  • 1. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
    Harosh-Davidovich SB; Khalaila I
    Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation in cancer development and immunotherapy.
    He XF; Hu X; Wen GJ; Wang Z; Lin WJ
    Cancer Lett; 2023 Jul; 566():216258. PubMed ID: 37279852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-specificity RNA aptamers enable manipulation of target-specific O-GlcNAcylation and unveil functions of O-GlcNAc on β-catenin.
    Zhu Y; Hart GW
    Cell; 2023 Jan; 186(2):428-445.e27. PubMed ID: 36626902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
    Phillips RM; Lam C; Wang H; Tran PT
    Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation is a gatekeeper of porcine myogenesis.
    Kirkpatrick LT; Daughtry MR; El-Kadi S; Shi TH; Gerrard DE
    J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 36219104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic β-cell hyper-O-GlcNAcylation leads to impaired glucose homeostasis
    Jo S; Pritchard S; Wong A; Avula N; Essawy A; Hanover J; Alejandro EU
    Front Endocrinol (Lausanne); 2022; 13():1040014. PubMed ID: 36387851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy.
    Papanicolaou KN; Jung J; Ashok D; Zhang W; Modaressanavi A; Avila E; Foster DB; Zachara NE; O'Rourke B
    J Biol Chem; 2023 Mar; 299(3):102907. PubMed ID: 36642184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells.
    Feinberg D; Ramakrishnan P; Wong DP; Asthana A; Parameswaran R
    Front Immunol; 2022; 13():841299. PubMed ID: 35479087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Integrated Role of Wnt/β-Catenin, N-Glycosylation, and E-Cadherin-Mediated Adhesion in Network Dynamics.
    Vargas DA; Sun M; Sadykov K; Kukuruzinska MA; Zaman MH
    PLoS Comput Biol; 2016 Jul; 12(7):e1005007. PubMed ID: 27427963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Fatty Acid Synthase Upregulates Glutamine-Fructose-6-Phosphate Transaminase 1 and O-Linked N-Acetylglucosamine Transferase to Increase O-GlcNAc Protein Glycosylation and Promote Colorectal Cancer Growth.
    Drury J; Geisen ME; Tessmann JW; Rychahou PG; Kelson CO; He D; Wang C; Evers BM; Zaytseva YY
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues.
    Chen L; Hu M; Chen L; Peng Y; Zhang C; Wang X; Li X; Yao Y; Song Q; Li J; Pei H
    Cancer Lett; 2024 Apr; 588():216742. PubMed ID: 38401884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC4 O-GlcNAcylation Regulates the Epithelial Phenotype in Conjunctival Epithelial Cells.
    Xiong WW; Ouyang ZJ; Tan Y; Xu LW; Peng XW
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38627316
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Luanpitpong S; Tangkiettrakul K; Kang X; Srisook P; Poohadsuan J; Samart P; Klaihmon P; Janan M; Lorthongpanich C; Laowtammathron C; Issaragrisil S
    Front Cell Dev Biol; 2024; 12():1361943. PubMed ID: 38752196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Essential Role of O-GlcNAcylation in Hepatic Differentiation.
    Robarts DR; Kotulkar M; Paine-Cabrera D; Venneman KK; Hanover JA; Zachara NE; Slawson C; Apte U
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential role of O-GlcNAcylation in hepatic differentiation.
    Robarts DR; Kotulkar M; Paine-Cabrera D; Venneman KK; Hanover JA; Zachara NE; Slawson C; Apte U
    Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37930118
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Fuentes-García G; Castañeda-Patlán MC; Vercoutter-Edouart AS; Lefebvre T; Robles-Flores M
    Front Endocrinol (Lausanne); 2019; 10():289. PubMed ID: 31139149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Nucleosomes Reveal that GlcNAcylation Modulates Direct Interaction with the FACT Complex.
    Raj R; Lercher L; Mohammed S; Davis BG
    Angew Chem Int Ed Engl; 2016 Jul; 55(31):8918-22. PubMed ID: 27272618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of extrinsic apoptotic pathway by intracellular glycosylation.
    Seyrek K; Ivanisenko NV; König C; Lavrik IN
    Trends Cell Biol; 2024 Feb; ():. PubMed ID: 38336591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New Chemical Reporter 6-Alkynyl-6-deoxy-GlcNAc Reveals O-GlcNAc Modification of the Apoptotic Caspases That Can Block the Cleavage/Activation of Caspase-8.
    Chuh KN; Batt AR; Zaro BW; Darabedian N; Marotta NP; Brennan CK; Amirhekmat A; Pratt MR
    J Am Chem Soc; 2017 Jun; 139(23):7872-7885. PubMed ID: 28528544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification.
    Dias WB; Cheung WD; Wang Z; Hart GW
    J Biol Chem; 2009 Aug; 284(32):21327-37. PubMed ID: 19506079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.